TABLE 1.
Demographic and clinical variables in MDD and HC groups
| MDD | HC | T/X2 value | p‐value | |
|---|---|---|---|---|
| Sample size | 20 | 32 | – | – |
| Age (years) | 40.05 ± 13.828 | 29.03 ± 6.832 | t = −3.319 | .003 |
| Gender (M: F) | 8:12 | 19:13 | X2 = 1.851 | .174 |
| Medication (n) | ||||
| NaSSA | 1 | – | – | – |
| SSRI | 2 | – | – | – |
| SSNRI | 3 | – | – | – |
| Tricyclic | 2 | – | – | – |
| Non‐declared | 6 | – | – | – |
| Naive | 6 | – | – | – |
| Psychometrics (mean ± SD) | ||||
| HDRS‐17 | 21.35 ± 4.31 | 1.31 ± 2.03 | t = −19.471 | .0001 |
| SEE | 8.40 ± 3.658 | 13.13 ± 2.862 | t = 4.224 | .0001 |
Abbreviations: HC, healthy control; HDRS, hamilton depression rating scale; MDD, major depressive disorder; NaSSA, noradrenergic and selective serotonergic antidepressant; SEE, skalen zum erleben von emotionen; SSNRI, selective serotonin and norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor.